Are you sure you want to exit?
Any unsave changes will be lost.
Capricor Therapeutics
Laboratory
United States of America (USA), North America
Capricor Therapeutics is providing CAP-1002, its novel cell therapy to patients with advanced COVID-19 under the compassionate use pathway
http://irdirect.net/prviewer/release/id/4280782